Your browser doesn't support javascript.
loading
Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
Shiels, Meredith S; Engels, Eric A; Yanik, Elizabeth L; McGlynn, Katherine A; Pfeiffer, Ruth M; O'Brien, Thomas R.
Afiliação
  • Shiels MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • Engels EA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • Yanik EL; Department of Orthopaedic Surgery, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
  • McGlynn KA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • O'Brien TR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
Cancer ; 125(15): 2621-2630, 2019 08 01.
Article em En | MEDLINE | ID: mdl-30980394
BACKGROUND: In the United States, incidence and mortality rates of hepatocellular carcinoma (HCC) are increasing in older individuals. Chronic infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) are important causes of HCC; however, the contribution of viral hepatitis to recent trends in HCC incidence among older Americans is unclear. METHODS: Data from the Surveillance, Epidemiology, and End Results-Medicare linkage (SEER-Medicare) for the years 2001 through 2013 were used to identify HCC cases among individuals aged ≥66 years and Medicare files were used to assess the HCV and HBV status of these HCC cases. Age-standardized incidence rates of HCV-attributable, HBV-attributable, and HCV/HBV-unrelated HCC were estimated overall and by age group, sex, and race/ethnicity. The authors also calculated annual percent changes (APCs) in HCC incidence. RESULTS: Between 2001 and 2013, a total of 15,300 HCC cases occurred in this population. Overall HCC rates increased 43% from 16.3 to 23.3 per 100,000 population (APC, 3.40% per year), whereas HCV-attributable HCC rates nearly doubled from 4.2 to 8.2 per 100,000 population (APC, 5.62% per year). HCC rates increased more slowly for HBV-attributable HCC (1.3 to 1.8 per 100,000 population; APC, 3.17% per year) and HCV/HBV-unrelated HCC (11.3 to 14.1 per 100,000 population; APC, 2.35% per year). The percentage of HCC cases with evidence of HCV infection increased from 25.7% in 2001 through 2004 to 32.3% in 2011 through 2013, whereas the percentage with HBV remained stable at 8%. In 2013, higher rates for both HCV-attributable and HBV-attributable HCC were noted among individuals aged 66 to 75 years, men, and individuals of Asian ancestry. CONCLUSIONS: Among Americans aged ≥66 years, HCC rates increased rapidly between 2001 and 2013. Although HCV-attributable cases contributed substantially to this increase, rates of HBV-attributable and HCV/HBV-unrelated HCC also rose during this period.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article